Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients
✍ Scribed by M. I. Wurzburger; G. M. Prelevic; P. H. Sönksen; M. Wheeler; L. Balint-Peric
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 401 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0940-5429
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulinlike growth factor I, serum levels of the high affinity growth hormone-b
The structure of IGF-I is similar to that of insulin, having 43 % sequence homology with human proinsulin. Both peptides can induce metabolic and mitogenic effects through their own specific receptors, which also share many structural and functional similarities. Primarily involved in the regulation
## Abstract The insulin‐like growth factors (IGFs) are potent mitogens for breast cancer cells and their activity is modulated by high affinity binding proteins (IGFBPs). We have recently shown that IGFBP‐1 purified from human amniotic fluid neutralizes IGF‐I‐dependent growth of MCF‐7 cells. In thi